RecruitingPhase 4NCT07471295

Toric Performance And Constant Evaluation

Prospective Assessment of Constant Optimization and Visual Outcomes Following Monofocal Toric IOL Implantation

Sponsor

Carl Zeiss Meditec AG

Enrollment

130 participants

Start Date

Jul 13, 2026

Study Type

INTERVENTIONAL

Conditions

Cataract

Summary

The main purpose of this investigation is to support safety and performance assessment of the investigational device with a focus on optimizing the IOL constants based on refractive outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Monofocal toric IOL for people with cataract. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMonofocal toric IOL

The device under investigation is a CE-approved monofocal bitoric, aspheric, aberration-correcting intraocular lens indicated for aphakia after surgical extraction of the cataractous natural lens and is also indicated for the correction of regular corneal astigmatism.